United States Biotechnology & Medical Research

Compass Therapeutics, Inc. (CMPX)

Track

Track

Compass Therapeutics, Inc. has seen no insider trading activity within the last ninety days. The most recent recorded transactions occurred in May 2025, involving executive share purchases. Prior to that period, significant divestments were executed by institutional stakeholders and directors during April 2025.
Ticker: CMPX Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Compass Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
492.10
Quantity 81,301 -4.6%
Value US$4,754,631
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Sale
Price
70.01
Quantity 91,856 -10.3%
Value US$90,231
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
89.07
Quantity 57,291 -0.4%
Value US$3,976,422
The Biotech Growth Trust PLC Director; Shareholder Non-Executive Director
Transaction date
Proposed sale
Price
1.59
Quantity 3,571,428
Value US$5,678,571
3.3
Anderman Jonathan Gen Counsel & Corporate Sec Officer
Transaction date
Purchase
Price
1.54
Quantity 20,000 +2000.0%
Value US$30,800
3.8
Lerner Neil CHIEF ACCOUNTING OFFICER Officer
Transaction date
Purchase
Price
1.42
Quantity 20,000 +6.7%
Value US$28,400
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.37
Quantity 10,000 +0.2%
Value US$33,700
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.98
Quantity 20,000 +0.3%
Value US$79,600
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.86
Quantity 20,000 +0.3%
Value US$77,200
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
4.05
Quantity 20,000 +0.4%
Value US$81,000
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
4.19
Quantity 20,000 +0.4%
Value US$83,800
2.6
Bisker-Leib Vered Chief Operating Officer Officer
Transaction date
Sale
Price
4.36
Quantity 2 -0.0%
Value US$9
2.6
Bisker-Leib Vered Chief Operating Officer Officer
Transaction date
Sale
Price
4.30
Quantity 9,569 -0.9%
Value US$41,147
2.6
Bisker-Leib Vered Chief Operating Officer Officer
Transaction date
Sale
Price
4.19
Quantity 14,929 -1.4%
Value US$62,553
2.6
Bisker-Leib Vered Chief Operating Officer Officer
Transaction date
Sale
Price
4.34
Quantity 16,035 -1.5%
Value US$69,592
2.6
Bisker-Leib Vered Chief Operating Officer Officer
Transaction date
Sale
Price
4.40
Quantity 6,226 -0.6%
Value US$27,394
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.21
Quantity 402,000 +2.7%
Value US$1,290,420
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.21
Quantity 402,000 +2.7%
Value US$1,290,420
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.32
Quantity 10,000 +0.2%
Value US$23,200
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.27
Quantity 15,000 +0.3%
Value US$34,050
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.03
Quantity 15,000 +0.3%
Value US$45,450
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.83
Quantity 15,000 +0.3%
Value US$42,450
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.05
Quantity 15,000 +0.3%
Value US$45,750
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.64
Quantity 15,000 +0.3%
Value US$39,600
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.58
Quantity 15,000 +0.3%
Value US$38,700
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.80
Quantity 20,000 +0.4%
Value US$56,000
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.34
Quantity 20,000 +0.4%
Value US$46,800
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.29
Quantity 30,000 +0.6%
Value US$68,700
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.83
Quantity 30,000 +0.6%
Value US$84,900
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.03
Quantity 20,000 +0.4%
Value US$60,600
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.04
Quantity 20,000 +0.4%
Value US$60,800
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.72
Quantity 18,355 +0.4%
Value US$49,926
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.47
Quantity 20,215 +0.4%
Value US$49,931
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.49
Quantity 30,722 +0.2%
Value US$76,498
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.49
Quantity 30,722 +0.2%
Value US$76,498
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.35
Quantity 97,094 +0.7%
Value US$228,171
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.35
Quantity 97,094 +0.7%
Value US$228,171
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.79
Quantity 64,700 +0.4%
Value US$115,813
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.79
Quantity 64,700 +0.4%
Value US$115,813
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
1.80
Quantity 27,836 +0.5%
Value US$50,105
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 24,447 +0.2%
Value US$39,115
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 24,447 +0.2%
Value US$39,115
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.56
Quantity 90,712 +0.6%
Value US$141,511
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.56
Quantity 90,712 +0.6%
Value US$141,511
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.63
Quantity 10,200 +0.1%
Value US$16,626
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.63
Quantity 10,200 +0.1%
Value US$16,626
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.50
Quantity 3,571,428 +inf%
Value US$12,499,998
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.50
Quantity 1,785,715 +14.0%
Value US$6,250,002
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.50
Quantity 3,571,428 +inf%
Value US$12,499,998
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.50
Quantity 1,785,715 +14.0%
Value US$6,250,002
Ferneau Philip Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 250,000 +166.4%
Value US$1,250,000
Sunderland Julie Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 289,118 +13.1%
Value US$1,445,590
Ferneau Philip Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 64,066 +2.8%
Value US$320,330
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,455,132 +12.9%
Value US$7,275,660
3.6
Schuetz Thomas J. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.00
Quantity 97,431 +2.2%
Value US$487,155
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,455,132 +12.9%
Value US$7,275,660
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-27 2025-05-27 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
81,301 -4.6%
492.10
US$4,754,631 		81,301 -4.6% 492.10 US$4,754,631
2025-04-11 2025-04-09 S Sale
1.6
GORDON CARL L
Non-Executive Director Large shareholder
91,856 -10.3%
70.01
US$90,231 		91,856 -10.3% 70.01 US$90,231
2025-04-11 2025-04-09 S Sale
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
57,291 -0.4%
89.07
US$3,976,422 		57,291 -0.4% 89.07 US$3,976,422
2025-04-09 2025-04-09 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Director; Shareholder

Non-Executive Director
3,571,428
1.59
US$5,678,571 		3,571,428 1.59 US$5,678,571
2025-04-09 2025-04-09 PrS Proposed sale
The Biotech Growth Trust PLC

Director; Shareholder

Non-Executive Director
3,571,428
1.59
US$5,678,571 		3,571,428 1.59 US$5,678,571
2025-04-08 2025-04-07 B Purchase
3.3
Anderman Jonathan

Gen Counsel & Corporate Sec

Officer
20,000 +2000.0%
1.54
US$30,800 		20,000 +2000.0% 1.54 US$30,800
2025-04-08 2025-04-07 B Purchase
3.8
Lerner Neil

CHIEF ACCOUNTING OFFICER

Officer
20,000 +6.7%
1.42
US$28,400 		20,000 +6.7% 1.42 US$28,400
2023-03-10 2023-03-10 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
10,000 +0.2%
3.37
US$33,700 		10,000 +0.2% 3.37 US$33,700
2023-02-27 2023-02-27 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.3%
3.98
US$79,600 		20,000 +0.3% 3.98 US$79,600
2023-02-15 2023-02-15 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.3%
3.86
US$77,200 		20,000 +0.3% 3.86 US$77,200
2023-01-31 2023-01-31 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
4.05
US$81,000 		20,000 +0.4% 4.05 US$81,000
2023-01-24 2023-01-24 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
4.19
US$83,800 		20,000 +0.4% 4.19 US$83,800
2022-11-25 2022-11-25 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
2 -0.0%
4.36
US$9 		2 -0.0% 4.36 US$9
2022-11-25 2022-11-23 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
9,569 -0.9%
4.30
US$41,147 		9,569 -0.9% 4.30 US$41,147
2022-11-25 2022-11-22 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
14,929 -1.4%
4.19
US$62,553 		14,929 -1.4% 4.19 US$62,553
2022-11-22 2022-11-21 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
16,035 -1.5%
4.34
US$69,592 		16,035 -1.5% 4.34 US$69,592
2022-11-22 2022-11-18 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
6,226 -0.6%
4.40
US$27,394 		6,226 -0.6% 4.40 US$27,394
2022-11-10 2022-11-08 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
402,000 +2.7%
3.21
US$1,290,420 		402,000 +2.7% 3.21 US$1,290,420
2022-11-10 2022-11-08 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
402,000 +2.7%
3.21
US$1,290,420 		402,000 +2.7% 3.21 US$1,290,420
2022-09-28 2022-09-28 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
10,000 +0.2%
2.32
US$23,200 		10,000 +0.2% 2.32 US$23,200
2022-09-27 2022-09-26 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.27
US$34,050 		15,000 +0.3% 2.27 US$34,050
2022-09-08 2022-09-07 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
3.03
US$45,450 		15,000 +0.3% 3.03 US$45,450
2022-09-01 2022-09-01 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.83
US$42,450 		15,000 +0.3% 2.83 US$42,450
2022-08-17 2022-08-17 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
3.05
US$45,750 		15,000 +0.3% 3.05 US$45,750
2022-08-10 2022-08-10 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.64
US$39,600 		15,000 +0.3% 2.64 US$39,600
2022-08-02 2022-08-01 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.58
US$38,700 		15,000 +0.3% 2.58 US$38,700
2022-06-21 2022-06-21 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
2.80
US$56,000 		20,000 +0.4% 2.80 US$56,000
2022-06-17 2022-06-16 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
2.34
US$46,800 		20,000 +0.4% 2.34 US$46,800
2022-06-13 2022-06-13 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +0.6%
2.29
US$68,700 		30,000 +0.6% 2.29 US$68,700
2022-06-07 2022-06-06 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +0.6%
2.83
US$84,900 		30,000 +0.6% 2.83 US$84,900
2022-06-01 2022-06-01 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
3.03
US$60,600 		20,000 +0.4% 3.03 US$60,600
2022-05-26 2022-05-26 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
3.04
US$60,800 		20,000 +0.4% 3.04 US$60,800
2022-05-24 2022-05-23 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
18,355 +0.4%
2.72
US$49,926 		18,355 +0.4% 2.72 US$49,926
2022-05-17 2022-05-17 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,215 +0.4%
2.47
US$49,931 		20,215 +0.4% 2.47 US$49,931
2022-05-13 2022-05-13 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
30,722 +0.2%
2.49
US$76,498 		30,722 +0.2% 2.49 US$76,498
2022-05-13 2022-05-13 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
30,722 +0.2%
2.49
US$76,498 		30,722 +0.2% 2.49 US$76,498
2022-05-13 2022-05-12 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
97,094 +0.7%
2.35
US$228,171 		97,094 +0.7% 2.35 US$228,171
2022-05-13 2022-05-12 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
97,094 +0.7%
2.35
US$228,171 		97,094 +0.7% 2.35 US$228,171
2022-05-13 2022-05-11 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
64,700 +0.4%
1.79
US$115,813 		64,700 +0.4% 1.79 US$115,813
2022-05-13 2022-05-11 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
64,700 +0.4%
1.79
US$115,813 		64,700 +0.4% 1.79 US$115,813
2022-05-10 2022-05-10 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
27,836 +0.5%
1.80
US$50,105 		27,836 +0.5% 1.80 US$50,105
2022-05-10 2022-05-10 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
24,447 +0.2%
1.60
US$39,115 		24,447 +0.2% 1.60 US$39,115
2022-05-10 2022-05-10 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
24,447 +0.2%
1.60
US$39,115 		24,447 +0.2% 1.60 US$39,115
2022-05-10 2022-05-09 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
90,712 +0.6%
1.56
US$141,511 		90,712 +0.6% 1.56 US$141,511
2022-05-10 2022-05-09 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
90,712 +0.6%
1.56
US$141,511 		90,712 +0.6% 1.56 US$141,511
2022-05-10 2022-05-06 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
10,200 +0.1%
1.63
US$16,626 		10,200 +0.1% 1.63 US$16,626
2022-05-10 2022-05-06 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
10,200 +0.1%
1.63
US$16,626 		10,200 +0.1% 1.63 US$16,626
2021-11-08 2021-11-04 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
3,571,428 +inf%
3.50
US$12,499,998 		3,571,428 +inf% 3.50 US$12,499,998
2021-11-08 2021-11-04 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
1,785,715 +14.0%
3.50
US$6,250,002 		1,785,715 +14.0% 3.50 US$6,250,002
2021-11-08 2021-11-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
3,571,428 +inf%
3.50
US$12,499,998 		3,571,428 +inf% 3.50 US$12,499,998
2021-11-08 2021-11-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,785,715 +14.0%
3.50
US$6,250,002 		1,785,715 +14.0% 3.50 US$6,250,002
2020-06-23 2020-06-19 B Purchase
Ferneau Philip
Non-Executive Director
250,000 +166.4%
5.00
US$1,250,000 		250,000 +166.4% 5.00 US$1,250,000
2020-06-23 2020-06-19 B Purchase
Sunderland Julie
Non-Executive Director
289,118 +13.1%
5.00
US$1,445,590 		289,118 +13.1% 5.00 US$1,445,590
2020-06-23 2020-06-19 B Purchase
Ferneau Philip
Non-Executive Director
64,066 +2.8%
5.00
US$320,330 		64,066 +2.8% 5.00 US$320,330
2020-06-23 2020-06-19 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
1,455,132 +12.9%
5.00
US$7,275,660 		1,455,132 +12.9% 5.00 US$7,275,660
2020-06-23 2020-06-19 B Purchase
3.6
Schuetz Thomas J.

Chief Executive Officer

Executive Director
97,431 +2.2%
5.00
US$487,155 		97,431 +2.2% 5.00 US$487,155
2020-06-23 2020-06-19 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,455,132 +12.9%
5.00
US$7,275,660 		1,455,132 +12.9% 5.00 US$7,275,660
Explore more

More insider trading research around Compass Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America